{"title":"Women’s socio-demographic and cultural factors influencing unmet need for family planning in rural areas of The Gambia: Evidence from a population-based analytical cross-sectional study","authors":"A. Barrow, E. Isah, E. Reynolds, A. Aisien","doi":"10.31586/gjeid.2022.304","DOIUrl":"https://doi.org/10.31586/gjeid.2022.304","url":null,"abstract":"","PeriodicalId":73167,"journal":{"name":"Global journal of epidemiology and infectious disease","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45204370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prevalence and predictors of physical activity among female high school students in The Gambia: an institutional-based cross-sectional study","authors":"A. Barrow, Balla Jammeh, Mansour Badjie","doi":"10.31586/gjeid.2022.300","DOIUrl":"https://doi.org/10.31586/gjeid.2022.300","url":null,"abstract":"","PeriodicalId":73167,"journal":{"name":"Global journal of epidemiology and infectious disease","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46486574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hadir Fathy Abdel-Rahman Ibrahim, A. A. Fotouh, M. Allam
{"title":"Healthcare Workers Should Receive Seasonal Influenza Vaccine during COVID-19 Pandemic?","authors":"Hadir Fathy Abdel-Rahman Ibrahim, A. A. Fotouh, M. Allam","doi":"10.31586/gjeid.2022.215","DOIUrl":"https://doi.org/10.31586/gjeid.2022.215","url":null,"abstract":"","PeriodicalId":73167,"journal":{"name":"Global journal of epidemiology and infectious disease","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45837884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Areej Mohamed Abdelhady Ahmed Helaly, G. Amin, S. A. Rahman, M. Allam
{"title":"Role of Ivermectin in Management of COVID-19","authors":"Areej Mohamed Abdelhady Ahmed Helaly, G. Amin, S. A. Rahman, M. Allam","doi":"10.31586/gjeid.2022.238","DOIUrl":"https://doi.org/10.31586/gjeid.2022.238","url":null,"abstract":"","PeriodicalId":73167,"journal":{"name":"Global journal of epidemiology and infectious disease","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46046743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Barrow, Afape Ayobami, Precious Chidozie Azubuike, D. Cham
{"title":"Prevalence and Determinants of Acute Respiratory Infections among Children under Five Years in Rural Settings of The Gambia: Evidence from a National Survey","authors":"A. Barrow, Afape Ayobami, Precious Chidozie Azubuike, D. Cham","doi":"10.31586/gjeid.2022.247","DOIUrl":"https://doi.org/10.31586/gjeid.2022.247","url":null,"abstract":"","PeriodicalId":73167,"journal":{"name":"Global journal of epidemiology and infectious disease","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48701403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rehab Mohamed Ali Mohamed, Ghada Essam El-Din Amin, Salwa Mostafa Mohammad Abdel Rahman, Mohamed Farouk Allam
{"title":"Melatonin could be used for Treatment of COVID-19?","authors":"Rehab Mohamed Ali Mohamed, Ghada Essam El-Din Amin, Salwa Mostafa Mohammad Abdel Rahman, Mohamed Farouk Allam","doi":"10.31586/gjeid.2022.188","DOIUrl":"https://doi.org/10.31586/gjeid.2022.188","url":null,"abstract":"","PeriodicalId":73167,"journal":{"name":"Global journal of epidemiology and infectious disease","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46864190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Retrospective, Cross-sectional Hospital-based Study to Determine the Epidemiological, Clinical and Comorbidity Characteristics in Older Adults with Psoriasis","authors":"K. Minni, M. Rajagopalan","doi":"10.31586/gjeid.2022.182","DOIUrl":"https://doi.org/10.31586/gjeid.2022.182","url":null,"abstract":"","PeriodicalId":73167,"journal":{"name":"Global journal of epidemiology and infectious disease","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47955066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kholoud Mohamed Elawady Elhefnawy Elshiwy, Ghada Essam El-Din Amin, M. Nazmy, R. Samir, Mohamed Farouk Allam
: CoV-2 disease 2019 (COVID-19) pandemic has exerted a great burden on the health and economic systems worldwide. One of the most important factors that affect the severity and prognosis of COVID-19 is the occurrence of hyperstimulation of the immune system resulting in “cytokine storm”. Similar to SARS -CoV, an intracellular complex called nod like receptor family pyrin domain containing 3 (NLRP3) inflammasome was found to be activated by SARS-CoV-2, then in turn stimulates several interleukins and initiates the inflammatory cascade. In addition, other inflammatory mediators such as interferons e.g., IFN- α, and IFN - γ, interleukins e.g., IL - 1β, IL-12, IL-18, tumor necrosis factor- α (TNF - α), and chemokines e.g., CCL2, CXCL10 have been reported in severely ill patients. These mediators represent the corner stone in developing cytokine storm that results in uncontrolled systemic inflammatory reaction with subsequent acute respiratory distress syndrome (ARDS), multiple organ failure and eventually death. Based on its an-ti-inflammatory effects, colchicine has also gained attention to be utilized in the management of COVID-19 patient. Colchicine exerts its anti-inflammatory effect through inhibition of formation of microtubules which is considered an essential step in several cellular processes such as division, signalling, and migration. Also, colchicine affects the cytokine cascade by inhibiting IL- 1β leading to reduction in neutrophils recruitment, free radicles production and inflammasome stimulation. This raises the concerns about the effectiveness of colchicine in COVID-19 treatment and the possibility of providing an improvement of the clinical course of the disease.
{"title":"Role of Colchicine in Management of COVID-19?","authors":"Kholoud Mohamed Elawady Elhefnawy Elshiwy, Ghada Essam El-Din Amin, M. Nazmy, R. Samir, Mohamed Farouk Allam","doi":"10.31586/gjeid.2022.177","DOIUrl":"https://doi.org/10.31586/gjeid.2022.177","url":null,"abstract":": CoV-2 disease 2019 (COVID-19) pandemic has exerted a great burden on the health and economic systems worldwide. One of the most important factors that affect the severity and prognosis of COVID-19 is the occurrence of hyperstimulation of the immune system resulting in “cytokine storm”. Similar to SARS -CoV, an intracellular complex called nod like receptor family pyrin domain containing 3 (NLRP3) inflammasome was found to be activated by SARS-CoV-2, then in turn stimulates several interleukins and initiates the inflammatory cascade. In addition, other inflammatory mediators such as interferons e.g., IFN- α, and IFN - γ, interleukins e.g., IL - 1β, IL-12, IL-18, tumor necrosis factor- α (TNF - α), and chemokines e.g., CCL2, CXCL10 have been reported in severely ill patients. These mediators represent the corner stone in developing cytokine storm that results in uncontrolled systemic inflammatory reaction with subsequent acute respiratory distress syndrome (ARDS), multiple organ failure and eventually death. Based on its an-ti-inflammatory effects, colchicine has also gained attention to be utilized in the management of COVID-19 patient. Colchicine exerts its anti-inflammatory effect through inhibition of formation of microtubules which is considered an essential step in several cellular processes such as division, signalling, and migration. Also, colchicine affects the cytokine cascade by inhibiting IL- 1β leading to reduction in neutrophils recruitment, free radicles production and inflammasome stimulation. This raises the concerns about the effectiveness of colchicine in COVID-19 treatment and the possibility of providing an improvement of the clinical course of the disease.","PeriodicalId":73167,"journal":{"name":"Global journal of epidemiology and infectious disease","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48437871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01Epub Date: 2021-11-10DOI: 10.31586/gjeid.2021.164
James A Koziol, Jan E Schnitzer
Background: Annual influenza outbreaks constitute a major public health concern in the United States. But this health burden appears dwarfed by the impact of COVID-19. Our aim is to quantify the excess mortality attributable to COVID-19, compared to previous influenza seasons.
Methods: We retrospectively compare weekly mortality figures attributable to influenza and pneumonia in the United States from 2013 to 2019 with corresponding figures attributable to influenza, pneumonia, and COVID-19 from 2019 to 2021. We utilize a difference in differences regression methodology to estimate excess mortality observed in 2019-21 compared to 2013-2019.
Results: Mortality patterns attributable to influenza, pneumonia, and COVID-19 differ significantly from the 2013-19 experience. Notably, distinct, aperiodic mortality waves occur in the 2019-2021 window, and mortality is well in excess of what is observed in typical influenza seasons.
Conclusions: The COVID-19 pandemic has led to considerable excess mortality in the United States, and has strained public health resources. One might expect that the mortality waves observed during the pandemic will be damped by increasing levels of vaccination, and prior infections.
{"title":"A Note on Excess Mortality Attributable to COVID-19 in the United States.","authors":"James A Koziol, Jan E Schnitzer","doi":"10.31586/gjeid.2021.164","DOIUrl":"10.31586/gjeid.2021.164","url":null,"abstract":"<p><strong>Background: </strong>Annual influenza outbreaks constitute a major public health concern in the United States. But this health burden appears dwarfed by the impact of COVID-19. Our aim is to quantify the excess mortality attributable to COVID-19, compared to previous influenza seasons.</p><p><strong>Methods: </strong>We retrospectively compare weekly mortality figures attributable to influenza and pneumonia in the United States from 2013 to 2019 with corresponding figures attributable to influenza, pneumonia, and COVID-19 from 2019 to 2021. We utilize a difference in differences regression methodology to estimate excess mortality observed in 2019-21 compared to 2013-2019.</p><p><strong>Results: </strong>Mortality patterns attributable to influenza, pneumonia, and COVID-19 differ significantly from the 2013-19 experience. Notably, distinct, aperiodic mortality waves occur in the 2019-2021 window, and mortality is well in excess of what is observed in typical influenza seasons.</p><p><strong>Conclusions: </strong>The COVID-19 pandemic has led to considerable excess mortality in the United States, and has strained public health resources. One might expect that the mortality waves observed during the pandemic will be damped by increasing levels of vaccination, and prior infections.</p>","PeriodicalId":73167,"journal":{"name":"Global journal of epidemiology and infectious disease","volume":"1 1","pages":"62-65"},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416805/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10002049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：